COLLISION OF PRIMARY ADENOCARCINOMA LUNG WITH METASTASIS ADENOCARCINOMA FROM COLON: A CASE REPORT
Abstract
Introduction: Collision tumors occur when two tumors of different histological origins develop simultaneously at the same site, such as sarcoma and carcinoma combinations, carcinoma and lymphoma combinations, or others. Notably, collision tumors are less common in the lungs compared to other organs.
Case description: A 65-year-old woman with a history of surgically and chemotherapeutically treated colon adenocarcinoma undergoes a regular chest radiographic check-up at a hospital. Follow-up examination and computed tomography reveal two oval lesions in the right lung lobe, later confirmed through histopathological and immunohistochemical analysis. One lesion is identified as primary lung adenocarcinoma, while the other represents a metastasis of colon adenocarcinoma. Diagnosis of lesions with distinct histological origins relies on determining the expression of specific markers. Lung adenocarcinoma typically expresses TTF-1 in 90% of cases, while metastases originating from colonic adenocarcinoma often exhibit CDX2 marker expression in 99% of cases.
Conclusion: Several theories attempt to explain the formation of collision tumors. The first hypothesis suggests that their origin lacks a specific pattern or predictable cause. The second hypothesis proposes that environmental changes, influenced by carcinogenic stimuli, promote the simultaneous growth of two tumors. Lastly, it is hypothesized that tumors modify the organ's microenvironment, increasing the likelihood of nearby metastatic colonization. To ensure effective treatment of collision tumors, accurate and precise diagnosis, along with a comprehensive understanding of the tumor's characteristics, is crucial.
References
1. Bulte CA, Hoegler KM, Khachemoune A. Collision tumors: A review of their types, pathogenesis, and diagnostic challenges. Dermatol Ther. 2020 Nov;33(6):e14236. doi: 10.1111/dth.14236. Epub 2020 Sep 15. PMID: 32852089.
2. Wang C, Zhao P, Shao Y, et al. [Clinical and pathological analysis collision carcinoma: report of 7 patients]. Zhonghua Wai Ke Za Zhi. 2002 Nov;40(11):838-9. Chinese. PMID: 12487858.
3. Yang C, Li S, Liang Z, et al. Case Report: The first case of primary pulmonary collision tumor comprising mixed squamous cell and glandular papilloma and glomus tumor. Front Oncol. 2022 Nov 21;12:1050220. doi: 10.3389/fonc.2022.1050220. PMID: 36479078; PMCID: PMC9720315..
4. Sung CT, Shetty A, Menias CO, et al. Collision and composite tumors; radiologic and pathologic correlation. Abdom Radiol (NY). 2017 Dec;42(12):2909-2926. doi: 10.1007/s00261-017-1200-x. PMID: 28623377.
5. Murthaiah P, Truskinovsky AM, Shah S, et al. Collision tumor versus multiphenotypic differentiation: a case of carcinoma with features of colonic and lung primary tumors. Anticancer Res. 2009 May;29(5):1495-7. PMID: 19443356.
6. Byun J, Schwartz AG, Lusk C, et al. Genome-wide association study of familial lung cancer. Carcinogenesis. 2018 Sep 21;39(9):1135-1140. doi: 10.1093/carcin/bgy080. PMID: 29924316; PMCID: PMC6148967.
7. Vatandoust S, Price TJ, Karapetis CS. Colorectal cancer: Metastases to a single organ. World J Gastroenterol. 2015 Nov 7;21(41):11767-76. doi: 10.3748/wjg.v21.i41.11767. PMID: 26557001; PMCID: PMC4631975.
8. Mitry E, Guiu B, Cosconea S, et al. Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study. Gut. 2010 Oct;59(10):1383-8. doi: 10.1136/gut.2010.211557. Epub 2010 Aug 23. PMID: 20732912.
9. Pihl E, Hughes ES, McDermott FT, et al. Lung recurrence after curative surgery for colorectal cancer. Dis Colon Rectum. 1987 Jun;30(6):417-9. doi: 10.1007/BF02556487. PMID: 3595358.
10. Prasanna T, Karapetis CS, Roder D, et al. The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern. Acta Oncol. 2018 Nov;57(11):1438-1444. doi: 10.1080/0284186X.2018.1487581. Epub 2018 Jul 23. PMID: 30035653.
11. Vidarsdottir H, Tran L, Nodin B, et al. Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases. Hum Pathol. 2019 Feb;84:221-230. doi: 10.1016/j.humpath.2018.10.009. Epub 2018 Oct 31. PMID: 30389437..
12. Su YC, Hsu YC, Chai CY. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma. Kaohsiung J Med Sci. 2006 Jan;22(1):14-9. doi: 10.1016/S1607-551X(09)70214-1. PMID: 16570563.
13 Brandwein-Gensler M, Urken M, Wang B. Collision tumor of the thyroid: a case report of metastatic liposarcoma plus papillary thyroid carcinoma. Head Neck. 2004 Jul;26(7):637-41. doi: 10.1002/hed.20024. PMID: 15229907.
14. Kanzaki R, Fukui E, Kanou T, et al. Preoperative evaluation and indications for pulmonary metastasectomy. J Thorac Dis. 2021 Apr;13(4):2590-2602. doi: 10.21037/jtd-19-3791. PMID: 34012607; PMCID: PMC8107542.
15. Gonzalez M, Poncet A, Combescure C, et al. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol. 2013 Feb;20(2):572-9. doi: 10.1245/s10434-012-2726-3. Epub 2012 Oct 28. PMID: 23104709.
16. Chiang XH, Lu TP, Hsieh MS, et al. Thoracoscopic Wedge Resection Versus Segmentectomy for cT1N0 Lung Adenocarcinoma. Ann Surg Oncol. 2021 Dec;28(13):8398-8411. doi: 10.1245/s10434-021-10213-9. Epub 2021 Jun 18. PMID: 34145505.
